MarketPulse

weight-loss medicine

2 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Viking Therapeutics' Billion-Dollar Bet: Can VK2735 Compete in the Weight-Loss Gold Rush?

Viking Therapeutics' VK2735 targets the $100+ billion weight-loss market. Success could drive massive stock appreciation, but clinical and competitive risks remain substantial.
LLYVKTXbiotechregulatory approval
BenzingaBenzinga··Vandana Singh

HSBC Slashes Eli Lilly Price Target, Warns Obesity Drug Market Vastly Overhyped

HSBC downgraded $LLY to Reduce, citing inflated obesity market projections. The analyst sees $80-120B market by 2032, not Wall Street's $150B estimate.
LLYNVOprice target cutmarket valuation